By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
A medical device called an implanted drug infusion system, commonly referred to as an implantable drug pump or an intrathecal drug delivery system, is used to deliver pharmaceuticals directly into certain body parts.
These systems are made to deliver drug administration continuously or as needed in order to treat disorders like chronic pain, spasticity, or others that call for specialized drug therapy medication pump, catheter, and programmer are some of the parts that make up an implantable medication infusion system.
Drug Pump: The medication is stored and delivered by a tiny, battery-operated device called a drug pump. Under the skin, usually in the abdomen, it is commonly inserted. The pump has a reservoir that stores the medication and a pumping system that administers the drug through the catheter in exact doses.
A tiny, flexible tube called a catheter is surgically placed close to the target spot to administer drugs. The intended site, such as the intrathecal region around the spinal cord or a particular target area within the body, is reached by threading it from the pump to the targeted place.
By bypassing the bloodstream and delivering localized therapy, the medicine is administered straight through the catheter to the desired spot. The drug infusion system is programmed and monitored by healthcare experts using an external device called a programmer. It enables the healthcare professional to modify the drug dosage, flow rate, and delivery schedule in accordance with the demands of the patient.
With the help of wireless communication between the programmer and the implanted drug pump, drug therapy can be precisely controlled and tailored. Compared to oral or systemic drug administration techniques, implantable medication infusion devices have a number of advantages:
Targeted therapy is made possible by the direct delivery of drugs to the appropriate site through implantable drug infusion systems. Higher drug concentrations can be achieved in the target location while reducing systemic negative effects by administering medications locally.
Systemic adverse effects of oral drugs, such as gastrointestinal problems or drowsiness, can be lessened because the treatment is given directly to the target region. This targeted delivery can lessen undesirable side effects while enhancing the therapeutic impact.
Continual or On-Demand administration: Depending on the patient’s requirements, implantable drug infusion devices can offer continuous or on-demand drug administration. While on-demand administration enables the patient to self-administer medication as needed, continuous infusion assures a constant quantity of medication in the intended location.
Medication Compliance is Improved: The automatic medication delivery provided by implantable drug infusion systems facilitates better medication compliance. Patients no longer have to consistently remember to take their medications on their own.
Dose titration is a feature of implantable medication pumps that enables medical personnel to modify the drug dosage as the patient’s condition varies over time. This adaptability enables tailored therapy and enhances symptom or pain management.
In situations where conventional treatments have failed, implantable medication infusion systems are frequently utilized to control chronic pain. Additionally, they can be used to manage spasticity brought on by illnesses like multiple sclerosis, cerebral palsy, or spinal cord injuries.
The use of implantable drug infusion devices does, however, necessitate cautious patient selection, proper patient education, and continuing medical supervision. To guarantee safe and efficient drug delivery, proper programming, routine pump refilling, and periodic review are necessary.
In conclusion, implantable drug infusion systems are sophisticated medical devices that deliver pharmaceuticals directly to selected body parts to give targeted drug therapy. These systems include advantages such as dose titration, continuous or on-demand drug administration, localized drug delivery, fewer systemic side effects, and enhanced medication compliance.
They are essential in the treatment of chronic pain and other illnesses that call for tailored medication therapy, giving patients more individualized treatment options and better quality of life.
The Global Implantable Drug Infusion Systems Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The US market launch of the Prometra® Programmable Intrathecal Drug Infusion Pump has been announced by Flowonix Medical Inc. The US launch of the Prometra programmable intrathecal pump was announced today by Flowonix Medical Inc., a medical device firm specializing in offering cutting-edge implanted drug delivery solutions.
For doctors who use Infumorph®, a preservative-free form of morphine, to treat patients with chronic pain, the Prometra pump offers significant additional improvements. Compared to currently available programmed pumps, the Prometra pump delivers greater precision and durability, both of which are crucial in treating patients with chronic pain with superior therapy.
Given the growing worry about the misuse of oral narcotics, programmable pumps provide clinicians with a critical treatment option for patients with chronic pain. Along with the financial and medical benefits of implantable pump therapy, the Prometra pump has cutting-edge technology for more precise drug administration and longer device life.
The Prometra pump features a revolutionary dual-gated valve drug delivery system that produces extremely accurate medicine dosing and greatly extends the pump’s lifespan because of the minimal number of moving components. A small amount of medication is delivered directly to the intrathecal area surrounding the spinal column via programmable intrathecal pumps, which are implanted in the body. This enables doctors to lower the patient’s daily drug requirement.
